Controlled release and angiotensin-converting enzyme inhibition properties of an antihypertensive drug based on a perindopril erbumine-layered double hydroxide nanocomposite.

Hussein Al Ali, Samer Hasan

Controlled release and angiotensin-converting enzyme inhibition properties of an antihypertensive drug based on a perindopril erbumine-layered double hydroxide nanocomposite. [electronic resource] - International journal of nanomedicine 2012 - 2129-41 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1178-2013

10.2147/IJN.S30461 doi


Aluminum Compounds--chemistry
Angiotensin-Converting Enzyme Inhibitors--administration & dosage
Antihypertensive Agents--administration & dosage
Cell Line
Cell Survival--drug effects
Delayed-Action Preparations
Drug Stability
Hepatocytes--drug effects
Humans
Intercalating Agents
Metal Nanoparticles--chemistry
Microscopy, Electron, Scanning
Models, Molecular
Nanocomposites--administration & dosage
Nanomedicine
Nitrates--chemistry
Perindopril--administration & dosage
Powder Diffraction
Spectroscopy, Fourier Transform Infrared
Surface Properties
Zinc--chemistry